✦ LIBER ✦

C5b-9 inhibitor (eculizumab) for antibody-mediated rejection in renal transplantation

✍ Scribed by Rizwan Hamer; Nithya Krishnan; David Lowe; David Briggs; Daniel Zehnder; Robert Higgins

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eculizumab Treatment of Acute Antibody-M

✍ González-Roncero, F.; Suñer, M.; Bernal, G.; Cabello, V.; Toro, M.; Pereira, P.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 672 KB

Eculizumab Treatment of Acute Antibody-M

✍ González-Roncero, F.; Suñer, M.; Bernal, G.; Cabello, V.; Toro, M.; Pereira, P.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 672 KB

Eculizumab for Salvage Treatment of Refr

✍ Kocak, B.; Arpali, E.; Demiralp, E.; Yelken, B.; Karatas, C.; Gorcin, S.; Gorgul 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Reversal of refractory antibody-mediated

✍ C. Morath; L.P. Kihm; M. Zeier; R. Waldher; J. Schmidt; A. Leo; C. Süsal; M. Kir 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB

New Therapeutic Approaches to Antibody-M

✍ Raghavaiah, S; Stegall, M D 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 185 KB

Acute Antibody-Mediated Rejection in Ren

✍ Schinstock, Carrie; Stegall, Mark D. 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 222 KB